<DOC>
	<DOCNO>NCT01587989</DOCNO>
	<brief_summary>This multicenter study randomize , double-blind , parallel-group phase evaluate safety efficacy RoActemra/Actemra ( tocilizumab ) combination methotrexate versus RoActemra/Actemra monotherapy patient mild moderate rheumatoid arthritis , inadequate response methotrexate . Patients receive RoActemra/Actemra 8 mg/kg intravenously every 4 week plus oral methotrexate 15-25 mg weekly 12 week . Patients good/moderate EULAR response randomize receive either RoActemra/Actemra plus methotrexate RoActemra/Actemra plus placebo follow 12 week . Anticipated time study treatment 6 month .</brief_summary>
	<brief_title>A Study RoActemra/Actemra ( Tocilizumab ) With Without Methotrexate Patients With Mild Moderate Rheumatoid Arthritis With Inadequate Response Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Rheumatoid arthritis &gt; /= 1 year duration Mild moderate disease activity screening ( DAS 28 &lt; /= 4.5 &gt; 2.6 ) On methotrexate treatment least 12 week , stable oral dose ( 10 ) 15 mg 25 mg/week least 6 week prior Day 1 Body weight &lt; /= 150 kg Oral corticosteroid must stable dose ( maximum 10 mg/day ) least 25 28 day prior baseline Major surgery ( include joint surgery ) within 8 week prior screen plan major surgery within 6 month baseline Rheumatic autoimmune disease rheumatoid arthritis Functional class IV American College Rheumatology ( ACR ) Classification Prior history current inflammatory joint disease rheumatoid arthritis Treatment biologic agent time prior baseline Treatment traditional DMARDs methotrexate within 1 month ( leflunomide 3 month ) prior baseline Intraarticular parenteral corticosteroid within 6 week prior baseline Previous treatment tocilizumab Pregnant lactate woman Uncontrolled disease state , asthma , psoriasis inflammatory bowel disease flare commonly treated oral parenteral corticosteroid Known active current history recurrent bacterial , viral , fungal , mycobacterial infection History currently active primary secondary immunodeficiency Evidence active malignant disease , malignancy diagnose within previous 5 year Active tuberculosis require treatment within previous 3 year Positive HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>